Myocardial Infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: The intervention group received three drops of REO (Barij Pharmaceutical Co., manufacturing license No. 4215 from the Ministry of Health). REO was poured on non-abs
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Having the first experience of acute chest pain Age of 30-70 years Having hemodynamic stability No history of mental illness, conscious of time, place and person Literacy Score 20 or higher on the overt and covert anxiety scale No olfactory disorder No addiction to smoking and drugs Absence of asthma, respiratory problems, and a history of allergies to plant odors
Exclusion criteria
Exclusion criteria: The use of benzodiazepines, sedatives, and opioids Sudden changes in hemodynamic status Dissatisfaction with patient cooperation during the study History of eczema and allergies to plants History of migraines and chronic headaches Active psychological disease as diagnosed by a physician Olfactory disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Measure the level of anxiety before the intervention and then after the intervention daily for 3 days. Method of measurement: Spielberger questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Haddadi
Sabzevar University of Medical Sciences
Outcome results
None listed